5G3 TalkMed

銘柄追加
  • 0.410
  • 0.0000.00%
10分遅延寄付前 04/30 16:59 CST
5.44億時価総額17.08直近PER

TalkMed について

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People’s Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

基本情報

銘柄コード5G3
設立日2013
従業員268
会計年度末12-31
住所3 Mount Elizabeth Mount Elizabeth Hospital Level 2
都市Singapore
国名シンガポール
郵便番号228510

経営陣

  • 名称
  • 役職
  • 年給
  • Dr. Peng Tiam Ang
  • Executive Director and Chief Executive Officer
  • --
  • Dr. Kei Siong Khoo
  • Executive Director and Chief Operating Officer
  • --
  • Boon Yong Lee
  • Chief Financial Officer and Joint Company Secretary
  • --
  • S. Chandra Das
  • Non-Executive Independent Chairman of the Board
  • --
  • Teong Jin George Lim
  • Non-Executive Director
  • --
  • Jen Howe Lim
  • Non-Executive Director
  • --
  • Ching Ching Leong
  • Non-Executive Director
  • --
  • Yock Hian Dan
  • Independent Director
  • --
  • Yih Pin Sitoh
  • Independent Director
  • --
  • Anne Low Jacqueline
  • Joint Company Secretary
  • --
  • Heng Chong Benny Lim
  • Joint Company Secretary
  • --

分析

アナリスト評価

データなし

目標株価

データなし

ホット
シンガポール株
総合人気
コード
現在値
変化率